France-Israel AI Week Bridges Healthcare Innovation and Collaboration

France-Israel AI Week: Advancing AI in Healthcare

When: June 25, 13:30 – 17:30
Where: Room 003, Naftali Building – Tel Aviv University
Directions: Pedestrian access via Gate 5, by car Gate 4

The French Embassy and the French Institute in Israel, together with the Foundation France-Israel, are hosting a bilateral event focused on the latest developments in AI applied to healthcare. This event is part of the Artificial Intelligence Week at Tel Aviv University.

Key speakers include Dr. Muriel Dahan, Director of Research & Development at Unicancer; Mr. Stephane Chaillou, Chief Digital Information Officer at Institut Gustave Roussy; and Mr. Yedidia Levy Zauberman, Senior Vice President of Public Affairs & Impact at Owkin. The event offers a platform to connect experts from both countries and promote AI innovation in healthcare.

Israel’s Position in AI-Powered Healthcare

Israel ranks among the global leaders in artificial intelligence, with approximately 2,200 specialized AI companies—almost triple the number from a decade ago. Digital healthcare is a standout sector, with 58% of HealthTech firms integrating AI into their products.

AI applications in Israeli healthcare include:

• Medical imaging & assisted diagnosis: Algorithms that support early detection of diseases.
• Drug discovery & development: Predictive models that speed up therapy creation.
• Personalized medicine: Using large medical datasets to customize treatments.
• Preventive healthcare & telemedicine: AI tools that improve risk assessment and access to care.

A Strong and Growing Ecosystem

In 2023, Israeli AI startups attracted $3.9 billion in funding, showing notable growth and resilience compared to other sectors. AI-focused ventures account for 47% of total startup investments in Israel, underscoring the strategic importance of this field.

One of Israel’s key advantages is its extensive digitized medical records, covering three decades and a population of 9 million. This wealth of data has supported the founding of healthcare AI startups and keeps Israel at the forefront of medical data use and healthcare innovation.

Boosting France-Israel Cooperation in AI & Healthcare

This event aims to:

• Encourage collaboration between French and Israeli healthcare AI experts.
• Discuss funding opportunities via Horizon Europe and bilateral partnerships.
• Highlight innovations from both countries and their potential impact on medicine.

Event Program

13:30 – Registration
14:00 – Opening Remarks
 Ilana Cicurel, Director French Institute
 Pr. Dan Peer, VP R&D Tel Aviv University

14:10 – 14:30 – Keynote Address
 Speaker: Prof. Ran Balicer
 Topic: The Role of AI in Transforming Healthcare

14:30 – 16:00 – AI Innovations in Healthcare: AI in Treatment & Patient Care
Moderator: Anat Naschitz, CEO 9xc / 9vc
Speakers:
 Dr. Talia Cohen Solal, CEO Neurokaire
 Dr. Muriel Dahan, Director Research & Development Unicancer
 Pr. Ran Balicer, Chief Innovation Officer, Clalit
 Dr. Stephane Chaillou, Chief Digital Information Officer, Gustave Roussy
 Pr. Noam Shomron, Faculty of Medicine – Tel Aviv University
 Pr. Roded Sharan, Faculty of Exact Sciences – Tel Aviv University

16:00 – 17:30 – AI in Pharma & Drug Development
Moderator: Shai Melcer, Innovation Authority, Bioconvergence
Speakers:
 Mati Gill, CEO Aion Labs
 Yedidia Levy-Zauberman, VP Global Affairs Owkin (to be confirmed)
 Representative from Sanofi / Teva or AstraZeneca (to be confirmed)

Closing Remarks:
 Aurelie Guthmann, Expertise France
 Muriel Haim, Fondation France Israel

Contact for Press

Sabine Aiache
Responsable Communication, Presse & Relations Publiques
Institut français d’Israël
Ambassade de France en Israël
Rothschild 7, Tel Aviv
Office: +972 (0)3-7968028
Cell: +972 (0)52-4367802
s.aiache@ambfr-il.org
institutfrancais-israel.com

Healthcare professionals interested in AI applications and developments can explore further resources and training to enhance their skills at Complete AI Training.